These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23699634)

  • 1. Preliminary success with combination treatment for osteoporosis.
    BMJ; 2013 May; 346():f3221. PubMed ID: 23699634
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and future treatments of secondary osteoporosis.
    Soriano R; Herrera S; Nogués X; Diez-Perez A
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):885-94. PubMed ID: 25432359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient.
    Neuprez A; Rompen E; Crielaard JM; Reginster JY
    Calcif Tissue Int; 2014 Jul; 95(1):94-6. PubMed ID: 24804929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone remodeling: new therapeutic approaches].
    Ferrari S
    Rev Med Suisse; 2009 Jun; 5(207):1325-8. PubMed ID: 19626933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2014 Sep; 56(1452):91-6. PubMed ID: 25247344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Toenders WG
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):879; author reply 879. PubMed ID: 16676521
    [No Abstract]   [Full Text] [Related]  

  • 7. Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.
    Tashjian AH; Gagel RF
    J Bone Miner Res; 2006 Mar; 21(3):354-65. PubMed ID: 16491282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
    Skiba K; Adamczak M; Wiecek A
    Przegl Lek; 2011; 68(7):391-5. PubMed ID: 22010479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with teriparatide in a patient with pregnancy-associated osteoporosis.
    Hellmeyer L; Boekhoff J; Hadji P
    Gynecol Endocrinol; 2010 Oct; 26(10):725-8. PubMed ID: 20230328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V; Clarke BL
    Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of osteoporosis with parathyroid hormone and teriparatide.
    Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
    Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF; Hamdy NA; Netelenbos JC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):132-7. PubMed ID: 16463613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of parathyroid hormone (teriparatide) on bone mass and quality in osteoporosis].
    Marumo K; Saito M
    Nihon Rinsho; 2011 Jul; 69(7):1264-9. PubMed ID: 21774369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 17. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Babb RR
    N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis.
    Liu H; Michaud K; Nayak S; Karpf DB; Owens DK; Garber AM
    Arch Intern Med; 2006 Jun; 166(11):1209-17. PubMed ID: 16772249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper.
    Goldhahn J; Féron JM; Kanis J; Papapoulos S; Reginster JY; Rizzoli R; Dere W; Mitlak B; Tsouderos Y; Boonen S
    Calcif Tissue Int; 2012 May; 90(5):343-53. PubMed ID: 22451221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complicated osteoporosis in progeroid syndrome: treatment with teriparatide.
    Iglesias Bolaños P; Guijarro de Armas G; Civantos Modino S; Vega Piñero B; Pavón de Paz I; Monereo Megías S
    J Clin Densitom; 2012; 15(1):116-9. PubMed ID: 22154431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.